1
|
Grassi L, McFarland D, Riba M, Ferrara M, Zaffarami G, Belvederi Murri M, Cruciata M, Caruso R. The Challenging Problems of Cancer and Serious Mental Illness. Curr Psychiatry Rep 2025; 27:41-57. [PMID: 39786658 PMCID: PMC11724792 DOI: 10.1007/s11920-024-01570-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 11/18/2024] [Indexed: 01/12/2025]
Abstract
PURPOSE OF REVIEW: Patients with Serious Mental Illness (SMI) are reported to be at higher risk for somatic disorders (e.g. cardiovascular and metabolic diseases) and higher mortality, compared to the general population, because of the consequences of SMI including psychotropic medication side effects, sedentary and unhealthy lifestyle, difficult access to physical health care. The aim of this review was to examine the current evidence regarding oncology, focusing on the problem of cancer among patients with SMI. RECENT FINDINGS: Compared to the general population, individuals with SMI showed a lower rate of screening for cancer, suboptimal standard cancer treatment, delayed treatment, and higher mortality from cancer. Several factors, including those related to the patient, the health-care system, and the social context, are involved in these negative outcomes. It is therefore necessary to raise awareness and alert clinicians in oncology settings to the challenging problem of cancer among patients with SMI, a marginalized and vulnerable segment of the population that can be at risk for not receiving proper cancer prevention and care. Evidence supports the mandatory need for an interdisciplinary approach involving psychiatry and mental health services.
Collapse
Affiliation(s)
- Luigi Grassi
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Via Fossato di Mortara 64a, Ferrara, 44121, Italy.
- University Hospital Psychiatric Unit, S. Anna Hospital and Local Health Trust, Ferrara, Italy.
| | - Daniel McFarland
- Department of Psychiatry, Wilmot Cancer Center, University of Rochester Medical Center, Rochester, NY, USA
| | - Michelle Riba
- Department of PsychiatryDepartment of PsychiatryPsycho-Oncology Program, University of Michigan, University of Michigan Rogel Cancer Center, Ann ArborAnn Arbor, MI, USA
| | - Maria Ferrara
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Via Fossato di Mortara 64a, Ferrara, 44121, Italy
- University Hospital Psychiatric Unit, S. Anna Hospital and Local Health Trust, Ferrara, Italy
| | - Giulia Zaffarami
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Via Fossato di Mortara 64a, Ferrara, 44121, Italy
| | - Martino Belvederi Murri
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Via Fossato di Mortara 64a, Ferrara, 44121, Italy
- University Hospital Psychiatric Unit, S. Anna Hospital and Local Health Trust, Ferrara, Italy
| | - Marco Cruciata
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Via Fossato di Mortara 64a, Ferrara, 44121, Italy
| | - Rosangela Caruso
- Institute of Psychiatry, Department of Neuroscience and Rehabilitation, University of Ferrara, Via Fossato di Mortara 64a, Ferrara, 44121, Italy
- University Hospital Psychiatric Unit, S. Anna Hospital and Local Health Trust, Ferrara, Italy
| |
Collapse
|
2
|
Leahy D, Irwin KE, Murphy G, D'Alton P. Cancer care for people with significant mental health difficulties (SMHD) - patient perspectives. J Psychosoc Oncol 2023; 42:506-525. [PMID: 38096170 DOI: 10.1080/07347332.2023.2291203] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 06/27/2024]
Abstract
OBJECTIVES People with significant mental health difficulties (SMHD) experience inequities in cancer care. This study aims to deepen understanding of cancer care for individuals with SMHD. METHOD We conducted semi-structured interviews with seven individuals with SMHD regarding their experiences accessing and engaging with cancer care from August 2021 to February 2022. Data were analyzed using thematic analysis where both inductive and deductive coding was adopted through the lens of the socio-ecological model (SEM) as a theoretical framework. RESULTS The main themes included intrapersonal, interpersonal and organizational barriers and facilitators to care with a specific focus on modifiable factors related to cancer care delivery. CONCLUSION This study provides further evidence for promoting collaborative mental health and cancer care delivery to prevent inequalities in cancer care for patients with SMHD. PRACTICE IMPLICATIONS Adopting an interdisciplinary, team-based approach to cancer care and help with patient navigation across services are potential factors in improving cancer care for individuals with SMHD.
Collapse
Affiliation(s)
- Dorothy Leahy
- Doctoral Programme in Clinical Psychology, School of Psychology, University College Dublin, Belfield, Ireland
| | - Kelly E Irwin
- Department of Psychiatry, Harvard Medical School, Massachusetts General Hospital Cancer Center, Boston, MA, USA
| | - Gerd Murphy
- Department of Psychiatry, University Hospital Waterford, Waterford, Ireland
| | - Paul D'Alton
- Doctoral Programme in Clinical Psychology, School of Psychology, University College Dublin, Belfield, Ireland
| |
Collapse
|
3
|
Grassi L, McFarland D, Riba M. The Risk and The Course of Cancer Among People with Severe Mental Illness. Clin Pract Epidemiol Ment Health 2023; 19:e174501792301032. [PMID: 38659632 PMCID: PMC11037550 DOI: 10.2174/17450179-v17-e211208-2021-ht2-1910-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2021] [Revised: 10/11/2021] [Accepted: 10/12/2021] [Indexed: 04/26/2024]
Abstract
The paucity of data regarding patients with Serious Mental Illness (SMI) and cancer is alarming given the fact that people with SMI, especially schizophrenia, bipolar disorders and severe depressive disorders, have in general poorer access to physical health care and higher morbidity and mortality because of physical illnesses. The aims of this review were to examine the current evidence from existing literature on the risk of developing cancer and its course among people with SMI. Equivocal results emerge regarding the risk of developing some kind of cancer among people with SMI, with contrasting data on a possible higher, similar or lower risk in comparison with the general population. In contrast, a series of studies have pointed out that patients with SMI who develop cancer are less likely to receive standard levels of cancer care, both in terms of screening, diagnosis and treatment. Also, the mortality for cancer has been confirmed to be higher than the general population. A global sensitization about these problems is mandatory in an era in which community psychiatry has been developed in all countries and that policies of prevention, treatment, follow up, and palliative care should regard all the segments of the population, including people with SMI, through an interdisciplinary approach.
Collapse
Affiliation(s)
- Luigi Grassi
- Department of Neuroscience and Rehabilitation, DInstitute of Psychiatry, University of Ferrara and University Hospital Psychiatric Unit, Ferrara, Italy
| | - Daniel McFarland
- Department of Medicine, Hofstra University, Northwell Health, Lenox Hill Hospital, New York, NY, US
| | - Michelle Riba
- Department of Psychiatry, University of Michigan, Ann Arbor, MI, USA
- Psycho-oncology Program, University of Michigan Depression Center and Rogel Cancer Center, Ann Arbor, MI, USA
| |
Collapse
|
4
|
Hwong AR, Vittinghoff E, Thomas M, Hermida R, Walkup J, Crystal S, Olfson M, Mangurian C. Breast Cancer Screening Rates Among Medicaid Beneficiaries With Schizophrenia. Psychiatr Serv 2023; 74:497-504. [PMID: 36226372 PMCID: PMC10104476 DOI: 10.1176/appi.ps.20220163] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
OBJECTIVE Women with serious mental illness are more likely to be diagnosed as having late-stage breast cancer than women without serious mental illness, suggesting a disparity in screening mammography. This study aimed to compare screening mammography rates in a nationally representative sample of Medicaid beneficiaries with and without schizophrenia. METHODS Medicaid Analytic eXtract files, 2007-2012, were used to identify a cohort of women ages 40-64 with schizophrenia who were eligible for Medicaid but not Medicare (N=87,572 in 2007 and N=114,341 in 2012) and a cohort without schizophrenia, frequency-matched by age, race-ethnicity, and state (N=97,003 in 2007 and N=126,461 in 2012). Annual screening mammography rates were calculated and adjusted for demographic characteristics and comorbid conditions. Multivariable logistic regression was used to estimate the association between beneficiary characteristics and screening mammography rates. RESULTS In 2012, 27.2% of women with schizophrenia completed screening mammography, compared with 26.8% of the control cohort. In the schizophrenia cohort, American Indian/Alaskan Native women had significantly lower odds of receiving mammography (OR=0.82, p=0.02) than White women, whereas Hispanic/Latina women had higher odds (OR=1.16, p<0.001). Women with schizophrenia and a nonalcohol-related substance use disorder had lower odds of receiving mammography (OR=0.74, p<0.001) than women without a substance use disorder. Having at least one medical visit in the past year (vs. no visits) increased the odds of receiving screening mammography (OR=5.08, p<0.001). CONCLUSIONS Screening mammography rates were similar between Medicaid-insured women with and those without schizophrenia. Interventions to increase uptake may need to focus on improving socioeconomic conditions and primary care engagement for vulnerable populations, regardless of psychiatric condition.
Collapse
Affiliation(s)
- Alison R Hwong
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| | - Eric Vittinghoff
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| | - Marilyn Thomas
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| | - Richard Hermida
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| | - James Walkup
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| | - Stephen Crystal
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| | - Mark Olfson
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| | - Christina Mangurian
- Department of Psychiatry and Behavioral Sciences (Hwong, Thomas, Mangurian) and Department of Epidemiology and Biostatistics (Vittinghoff, Thomas), University of California, San Francisco (UCSF), San Francisco; UCSF National Clinician Scholars Program, San Francisco Veterans Affairs Medical Center, San Francisco (Hwong); Institute for Health, Rutgers University, New Brunswick, New Jersey (Hermida, Walkup, Crystal); Department of Psychiatry, Columbia University Medical Center, New York City (Olfson); UCSF Center for Vulnerable Populations, Zuckerberg San Francisco General Hospital, San Francisco (Mangurian)
| |
Collapse
|